HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics AG (NBRV), sold 24,479 shares at $10.95 ($268K) on 2017-07-03, disclosed to the SEC on 2017-07-05.
Open-market sale of $268k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.94 | 1,775 | $19K | 7.2% |
| 2 | $10.95 | 11,352 | $124K | 46.4% |
| 3 | $10.95 | 11,352 | $124K | 46.4% |
| Total | $10.95 avg | 24,479 | $268K | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |